In AlexSam, Inc. v. Aetna, Inc., the US Court of Appeals for the Federal Circuit held that de novo review is the appropriate appellate standard of review for a trial court’s determination that a patent infringement complaint’s allegations are merely “conclusory” and need not be taken as true on a motion to dismiss.
Source link
